GlassScriptPhysician profile
Kaitlin Williamson
NPI 1063862399
$7,911.44
in general payments reported to CMS, 2019-2025
39 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,325 · 2022: $2,064 · 2023: $1,232 · 2024: $1,231 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,522.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,672.23 | 2021-2025 | |
| Novo Nordisk INC | $1,228.55 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $623.65 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $595.80 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $455.67 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.26 | 2021-2024 | Jardiance |
| Ironwood Pharmaceuticals, INC | $287.29 | 2021-2024 | Linzess |
| Glaxosmithkline, LLC. | $243.28 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Sanofi-Aventis U.S. LLC | $214.45 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $200.18 | 2021-2024 | Eliquis |
| Biohaven Pharmaceutical Holding Company LTD. | $196.67 | 2022 | |
| Almatica Pharma LLC | $182.13 | 2022 | |
| Abbott Laboratories | $146.36 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $142.30 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $130.73 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.